Steven Isaacman
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$13.6MFederal grants as PI19 awards
0Patents grantedNone matched
4Papers207 citations
Federal awards and patents by year
AwardsPatents
19 awards · $13.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 7, 2026 | NIH | SBIR Phase I An indoor insecticide intervention to reduce allergen exposure and improve health outcomes for children with asthma in underserved communities | $314K | NANOMETICS LLC |
| Jul 26, 2024 | NIH | SBIR Phase II A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis | $1.0M | NANOMETICS LLC |
| Sep 14, 2023 | NIH | SBIR Phase II A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis | $1.0M | NANOMETICS LLC |
| Jun 9, 2021 | NIH | SBIR Phase II The Development of Inorganic Ultraviolet Filters Exhibiting Improved Topical Retention on Human Skin for The Prevention of Skin Cancer | $1.0M | NANOMETICS LLC |
| May 12, 2021 | NIH | SBIR Phase I Furthering the clinical development of a first in class, water resistant sunscreen to meet emerging environmental regulations | $399K | NANOMETICS LLC |
| Jun 25, 2020 | NIH | SBIR Phase II The Development of Inorganic Ultraviolet Filters Exhibiting Improved Topical Retention on Human Skin for The Prevention of Skin Cancer | $1.0M | NANOMETICS LLC |
| Nov 30, 2018 | NIH | SBIR Phase II A Phase 2 clinical trial of topical uracil for the prevention of capecitabine induced hand-foot syndrome | $999K | NANOMETICS LLC |
| Sep 18, 2018 | NIH | SBIR Phase I The Development of Inorganic Ultraviolet Filters Exhibiting Improved Topical Retention on Human Skin for The Prevention of Skin Cancer | $225K | NANOMETICS LLC |
| Mar 30, 2018 | NIH | SBIR Phase I A repurposed molecule as an oral therapeutic to improve vascular flow in sickle cell disease | $225K | NANOMETICS LLC |
| Nov 28, 2017 | NIH | SBIR Phase II A Phase 2 clinical trial of topical uracil for the prevention of capecitabine induced hand-foot syndrome | $1 | NANOMETICS LLC |
| Dec 28, 2016 | NIH | SBIR Phase II A Phase 2 clinical trial of topical uracil for the prevention of capecitabine induced hand-foot syndrome | $1000K | NANOMETICS LLC |
| Dec 28, 2016 | NIH | SBIR Phase II A Phase 2 clinical trial of topical uracil for the prevention of capecitabine induced hand-foot syndrome | $2.0M | NANOMETICS LLC |
| Jul 26, 2016 | NIH | SBIR Phase II The Translational Development of a Therapeutic For Triple Negative Breast Cancer | $750K | NANOMETICS LLC |
| Apr 1, 2016 | NIH | SBIR Phase I A targeted drug for the treatment of inflammation in cystic fibrosis lung disease | $225K | NANOMETICS LLC |
| Mar 6, 2016 | NIH | SBIR Phase I A targeted drug for the treatment of inflammation in cystic fibrosis lung disease | $225K | NANOMETICS LLC |
| Aug 19, 2015 | NIH | SBIR Phase II The Translational Development of a Therapeutic For Triple Negative Breast Cancer | $750K | NANOMETICS LLC |
| Aug 19, 2015 | NIH | SBIR Phase II The Translational Development of a Therapeutic For Triple Negative Breast Cancer | $1.5M | NANOMETICS LLC |
| Aug 14, 2015 | NIH | SBIR Phase II Schiff base forming sunscreen filters for long-wear UV protection | $750K | NANOMETICS LLC |
| Aug 10, 2015 | NIH | SBIR Phase I A targeted immunomodulator for the treatment of acute sickle crisis | $225K | NANOMETICS LLC |
1 patents as inventor
- US NANOMETICS LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#29
Awards as PI#32
Patents#505
Companies
- NANOMETICS LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.